We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

113 hedge funds and large institutions have $642M invested in Adverum Biotechnologies in 2015 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $4.33M

200% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 15

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

35% more funds holding

Funds holding: 84 → 113 (+29)

11% less capital invested

Capital invested by funds: $719M → $642M (-$76.8M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
113
Holders Change
+29
Holders Change %
+34.52%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
45
Increased
37
Reduced
22
Closed
15
Calls
$13.4M
Puts
$4.33M
Net Calls
+$9.09M
Net Calls Change
+$9.09M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$21.3M
2
Invesco
Invesco
Georgia
+$16.5M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$16M
4
RIM
RS Investment Management
California
+$14.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$35.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$21.1M
3
CI
Cowen Inc
New York
-$13.4M
4
RG
Redmile Group
California
-$11.7M
5
FCM
Frontier Capital Management
Massachusetts
-$9.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$4.05M +$4.23M +10,000 New
QF
27
QVT Financial
New York
$3.69M -$712K -1,685 -16%
EMFAT
28
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.35M +$3.9M +9,234 New
Northern Trust
29
Northern Trust
Illinois
$3.34M +$476K +1,125 +16%
QSS
30
Quantitative Systematic Strategies
Florida
$3.21M +$3.4M +8,046 New
Jennison Associates
31
Jennison Associates
New York
$3.18M +$10.6K +25 +0.3%
RSCM
32
Rock Springs Capital Management
Maryland
$2.86M +$2.98M +7,050 New
FCM
33
Farallon Capital Management
California
$2.63M +$2.75M +6,500 New
Allianz Asset Management
34
Allianz Asset Management
Germany
$2.59M +$2.71M +6,401 New
SFM
35
Sphera Funds Management
Israel
$2.43M +$2.54M +6,000 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$2.27M +$474K +1,122 +25%
SM
37
Sabby Management
Florida
$2.23M -$3.71M -8,786 -62%
RI
38
RTW Investments
New York
$2.08M +$55K +130 +3%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.01M +$677K +1,601 +48%
GOCM
40
Green Owl Capital Management
New York
$1.82M +$803K +1,900 +73%
RPAM
41
Rhenman & Partners Asset Management
Sweden
$1.74M +$1.82M +4,300 New
UOC
42
UBS O'Connor
Illinois
$1.64M +$1.71M +4,047 New
DCM
43
Driehaus Capital Management
Illinois
$1.58M -$326K -771 -16%
EAM
44
Eventide Asset Management
Massachusetts
$1.51M +$211K +500 +15%
ACPU
45
Arrowgrass Capital Partners (US)
Delaware
$1.41M -$1.24M -2,940 -46%
Group One Trading
46
Group One Trading
Illinois
$1.31M +$1.37M +3,241 New
UBS Group
47
UBS Group
Switzerland
$1.27M +$1.32M +3,128 New
TI
48
Turner Investments
Pennsylvania
$1.21M +$1.26M +2,982 New
Norges Bank
49
Norges Bank
Norway
$1.11M +$1.15M +2,732 New
Principal Financial Group
50
Principal Financial Group
Iowa
$1.09M – – –
1
2
3 4 5

ADVM Hedge Fund Activity: Q1 2015 in Review

113 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q1 2015, worth a combined $642M — down 11% from $719M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new ADVM positions and 15 closed out — a net gain of 30 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was Deerfield Management, adding an estimated $21.3M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $35.1M sold.

  • 113 institutional investors held Adverum Biotechnologies (ADVM) as of Q1 2015, up from 84 in Q4 2014.
  • Funds reported $642M of Adverum Biotechnologies stock for Q1 2015, down 11% quarter-over-quarter.
  • 45 funds opened new Adverum Biotechnologies positions in Q1 2015 and 15 closed out, a net change of +30 holders.
  • The largest Adverum Biotechnologies buyer in Q1 2015 was Deerfield Management, an estimated $21.3M added.
  • The largest Adverum Biotechnologies seller in Q1 2015 was Adage Capital Partners, an estimated $35.1M sold.

Based on aggregated 13F filings for Q1 2015.